PATENT CLAIM ANALYSIS

Application Number: 15863773
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Claim (Index 8):
A method of treating a neurological disease in a subject in need thereof, wherein the subject has an elevated level, or is predicted to have an elevated level of \u03b1-synuclein, ApoE4, or an undesired form thereof the method comprising administering an effective amount of an SCD inhibitor to the subject.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 86.0
- Lexical Diversity: 1.32258
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10566857', '14790313', '10901563', '14776184', '13238081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564450447802992
- 35 USC 102 Novelty (BERT): 0.5230546214174456
- Combined Prediction Score: 0.7331060024440138
- Mean Citation Score: 300.7376799999999
- Max Citation Score: 312.52133
- Similarity Product: 185.6938455693161

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test